Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cells ; 32(4): 325-31, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21874540

ABSTRACT

Ceramide has been suggested to be not only a tumor-suppressive lipid but also a regulator of phagocytosis. We examined whether exogenous cell-permeable C(6)-ceramide enhances the phagocytic activity of Kupffer cells (KCs) and affects the level of cellular ceramides. Rat KCs were isolated by collagenase digestion and differential centrifugation, using Percoll system. Phagocytic activity was measured by FACS analysis after incubating KCs with fluorescence-conjugated latex beads, and the level of cellular ceramide was analyzed by liquid chromatography tandem-mass spectrometry (LC-MS/MS). In this study we found that permeable C(6)-ceramide increases the cellular levels of endogenous ceramides via a sphingosine-recycling pathway leading to enhanced phagocytosis by KCs.


Subject(s)
Ceramides/pharmacology , Gene Expression Regulation , Kupffer Cells/drug effects , Liver/pathology , Phagocytosis , Animals , Cell Separation , Cells, Cultured , Ceramides/genetics , Ceramides/metabolism , Flow Cytometry , Gene Expression Regulation/drug effects , Immunity, Innate/drug effects , Kupffer Cells/metabolism , Kupffer Cells/pathology , Male , Phagocytosis/drug effects , Rats , Rats, Sprague-Dawley , Sphingosine/metabolism
2.
Toxicol Res ; 24(4): 315-320, 2008 Dec.
Article in English | MEDLINE | ID: mdl-32038810

ABSTRACT

Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a glycoprotein and hematopoietic growth factors that regulates the proliferation of myeloid precursor cells and activates mature granulocytes and macrophages. In a previous study, we reported that hGM-CSF could be produced in transgenic rice cell suspension culture, termed rhGM-CSF. In the present study, we examined the repeated dose toxicity of rhGM-CSF in SD rats. The repeated dose toxicity study was performed at each dose of 50 and 200 µg/kg subcutaneous administration of rhGM-CSF everyday for 28-days period. The results did not show any changes in food and water intake. There were also no significant changes in both body and organ weights between the control and the tested groups. The hematological and blood biochemical parameters were statistically not different in all groups. These results suggest that rhGM-CSF may show no repeated dose toxicity in SD rats under the conditions.

SELECTION OF CITATIONS
SEARCH DETAIL
...